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Abstract: This paper presents a biosensor-CMOS platform for measuring the capacitive coupling
of biorecognition elements. The biosensor is designed, fabricated, and tested for the detection and
quantification of a protein that reveals the presence of early-stage cancer. For the first time, the
spermidine/spermine N1 acetyltransferase (SSAT) enzyme has been screened and quantified on the
surface of a capacitive sensor. The sensor surface is treated to immobilize antibodies, and the baseline
capacitance of the biosensor is reduced by connecting an array of capacitors in series for fixed exposure
area to the analyte. A large sensing area with small baseline capacitance is implemented to achieve a
high sensitivity to SSAT enzyme concentrations. The sensed capacitance value is digitized by using a
12-bit highly digital successive-approximation capacitance-to-digital converter that is implemented
in a 0.18 µm CMOS technology. The readout circuit operates in the near-subthreshold regime and
provides power and area efficient operation. The capacitance range is 16.137 pF with a 4.5 fF absolute
resolution, which adequately covers the concentrations of 10 mg/L, 5 mg/L, 2.5 mg/L, and 1.25 mg/L
of the SSAT enzyme. The concentrations were selected as a pilot study, and the platform was shown
to demonstrate high sensitivity for SSAT enzymes on the surface of the capacitive sensor. The tested
prototype demonstrated 42.5 µS of measurement time and a total power consumption of 2.1 µW.
Keywords: biosensor; interdigitated electrodes; SSAT enzyme diagnostic platform; capacitive sensor
interface; early cancer detection; CMOS
1. Introduction
Limited access to health-care systems and less healthy lifestyles in third world countries emphasize
the need for low-cost point-of-care diagnostic systems [1]. Many drugs available in the market are
designed to kill, attack, or at least slow the growth of cancer cells. In short, they are poisons with
accompanying side effects. To avoid these side effects, many other cancer therapies have been
pursued. One of the latest therapies for cancer includes metabolomics–based tests. Metabolomics,
one of the “omic” sciences in systems biology, is the global assessment and validation of endogenous
small-molecule biochemicals (metabolites) within a biologic system [2]. The metabolomics-based
test consists of a single, one-shot application of amantadine, a drug which is already approved in
both the US and Canada, after which a urine sample is collected two to four hours later and then
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analyzed. Acetyl amantadine (AcAm) is recognized as an exogenous cancer biomarker because it is
the product of a metabolic process that is known to be significantly upregulated in cancerous cells.
After ingestion, the anti-Parkinson and anti-viral drug amantadine is acetylated in the body by the
enzyme spermidine/spermine N1 acetyltransferase (SSAT) to give AcAm, which can be detected in
patient urine. Enzymes have been quantified using solid phase extraction (SPE) and tandem liquid
chromatography with mass spectrometry (LCMS) from urine samples [3]. Raman spectroscopy is
employed in medical diagnostics due to its ability to characterize and identify molecules with an
inherent specificity [4]. Further, sensitivity in quantification is improved by Surface Enhanced Raman
Scattering (SERS) [5]. However, techniques previously used to quantify AcAm in urine, such as liquid
chromatography-mass spectrometry (LC-MS), are undesirable for clinical adoption due to high costs
and long run times [6]. Therefore, there is a need to develop low-cost, fast, and portable diagnostic
platforms to screen for the SSAT enzyme.
The SSAT enzyme production varies from person to person depending on the diet and lifestyle of
the person. If the concentration of SSAT enzyme in the blood is higher than the normal production of
theses enzymes then further diagnostics are required to precisely detect cancer progress. Almost all
cells produce polyamines that include spermidine and spermine, but the increased amounts are
prevailed in rapidly multiplying cells [7]. To show a dynamic range and sensitivity, a study on a
population of different regions needs to be carried out to provide statistical analysis. Our aim is to
provide an early-stage cancer detection system rather than monitoring the progression of cancer. As a
pilot study, various concentrations were screened from 10 to 1.25 mg/L of the SSAT enzyme.
Recently, diagnostic platforms have been widely used to measure various types of analytes.
These platforms include DNA analysis [8–10], protein quantification [11–15], and bacteria/cell growth
monitoring [16–18]. Beyond these, CMOS biosensors are promising, as they can provide outstanding
performance in sensing element and signal processing.
In in vitro diagnosis, different transducing mechanisms have been introduced for protein
quantification. Optical sensing is reported in [13]. The photodetectors are used to transduce the
optical properties from the fluorescence labels into an electrical signal. However, an excitation light
source, filtering, and sophisticated sample pre-processing are required which increase the complexity
of the biosensor and the power consumption. Another technique is to use an electrode or impedance
sensor for enzyme/protein detection [19,20]. However, a potentiostat or network/impedance analyzer
is utilized for interfacing the biosensor which is high-cost, large-sized, and complicated. Another
approach that uses magnetism sensing has been proposed [12,21]. Hall sensors have been employed to
transduce the magnetic field to voltage/current signals, and giant magnetoresistive (GMR) sensors are
used in resistive sensing of the magnetic field. However, this type of sensing needs magnetic-particle
labeling and magnetically sensitive transducers for which the GMR sensors are not available in
standard CMOS technology. Moreover, signal amplification and conditioning are needed for the sensed
signals, which increase the power consumption of the biosensor. Capacitive biosensors are promising
as point-of-care devices due to their simple, low-cost structure, rapid detection, and portability.
Moreover, capacitive sensors do not consume static power, and can be co-integrated with CMOS
circuitry. Therefore, they are very attractive for use in battery-powered systems. Capacitive biosensors
for protein detection are proposed in [22,23], where an LCR meter has been used for capacitance
measurements. The LCR meter is a bulky, complicated, and expensive instrument. However, energy
efficient integrated capacitance-to-digital converter circuitry can digitize the capacitance measurements
with very low power consumption [24–29].
In this paper, we introduce an in vitro diagnostic biosensor-CMOS platform to screen the SSAT
enzyme for low-power, rapid detection, and low cost. The sensing element is implemented based
on capacitive sensing. It has a large sensing area with small baseline capacitance (femtofarad
range) by connecting the capacitors in series, which increases the sensitivity and reduces the power
consumption on the side of the readout circuit. The readout circuit is realized by a capacitance-domain
successive-approximation (SAR) technique. It uses an inverter-based circuit that allows supply-voltage
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scaling for low-power requirement. Moreover, the readout circuit uses a clocked inverter-based
quantizer for cascaded amplification by turning cascaded quantizers off when they are not in use.
Thus, the average power of the quantizer is reduced. A binary-weighted capacitive digital-to-analog
converter (DAC) is implemented by using a coarse-fine architecture to cover the wide dynamic range
of the SSAT enzyme concentrations while occupying a small chip area.
The remainder of this paper is organized as follows. Section 2 provides a detailed description of
the materials and the capacitive sensing element. Section 3 presents the readout circuit architecture and
operation. Measurement results are discussed in Section 4, and the conclusion is drawn in Section 5.
2. Materials and Capacitive Sensing Element
2.1. Capacitive Biosensor
The fabrication process of the capacitive sensing element is shown in Figure 1. A glass substrate
of 500 µm thickness is submersed in a hot piranha solution, then washed with distilled water and
dried in a nitrogen drier. Ten nanometer (10 nm) titanium (Ti) and 400 nm gold (Au) metal layers are
deposited by sputtering at 5 mTorr vacuum with 400 Wdc energy. The photolithography process is
used to pattern the layers. Next, a dry etch process utilizing argon (Ar) gas at 300 W plasma power
is used to etch the exposed metal to form the electrodes, then the photoresist is removed by using
acetone and Isopropyl Alcohol (IPA).
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Figure 2. The sensor micrograph. 
The capacitive sensor is a 9-segment array, as shown in Figure 2f. Each segment was realized 
with interdigitated electrodes fabricated on a glass substrate. The thickness of the metal finger is 410 
nm with 50 μm of inner spacing between the fingers. The dielectric layer is then deposited by 
chemical vapor deposition (CVD) to form a 50 nm silicon nitride layer. After that, the capacitive 
sensor is coated with a 300 nm thin film of Parylene C to enhance the isolation and to keep it in the 
dynamic range of the readout circuit after depositing the analyte. The measured baseline capacitance 
Figure 1. Fabrication of capacitive sensing element: (a) Clean glass substrate; (b) Sputtering of 10 nm
Ti and 400 nm Au; (c) Photoresist coating; (d) Patterning of photoresist; (e) Photoresist develop, dry
etching, and photoresist removal (f) Dielectric deposition Si3N4 (50 nm)/Parylene C (300 nm).
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The capacitive sensor is a 9-segment array, as shown in Figure 2f. Each segment was realized with
interdigitated electrodes fabricated on a glass substrate. The thickness of the metal finger is 410 nm
with 50 µm of inner spacing between the fingers. The dielectric layer is then deposited by chemical
vapor deposition (CVD) to form a 50 nm silicon nitride layer. After that, the capacitive sensor is coated
with a 300 nm thin film of Parylene C to enhance the isolation and to keep it in the dynamic range
of the readout circuit after depositing the analyte. The measured baseline capacitance of the sensor,
which has a 2.92 mm × 3 mm area to cover the droplet of the biology sample, is 26 fF. The micrograph
of the sensor is shown in Figure 2.
2.2. Sample Sites
The following materials were used for surface modification of the sensor and experiments.
SSAT antibody was purchased from Santa Cruz Biotechnology, Inc. (Dallas, TX, USA) [30].
Spermidine-spermine+N1-Acetyltransferase+1+SAT1 was purchased from Insight Biotechnology.
Tween-20, glutaraldehyde, and bovine serum albumin (BSA) were purchased from Sigma.
2.3. Surface Modification and Antibody immobilization
The detailed procedure of the antibodies immobilization on Parylene C is shown in Figure 3.
The cleaned surfaces of the capacitive sensors were incubated in 5% glutaraldehyde solution
(cross-linking agent) in 1× PBS (phosphate buffer saline) solution (pH 7.4) and kept for 2 h in an
inert argon atmosphere inside an enclosed chamber. Argon gas aids in absorbing active agents on the
treated surface and covalently couples the active agent to the surface of the substrate [31]. The most
common group present on the exterior of a protein is lysine with amino groups. Glutaraldehyde helps
in the crosslinking of proteins to proteins or proteins to a surface-immobilized substrate due to the
presence of its two amine functional groups [32].
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The capacitive biosensor can be reused with extensive cleaning and recalibration of the sensors. 
However, they get attached to the readout circuit via a simple connector and can be made disposable 
due to the reduced cost of manufacturing them [22–34], while the electronic readout system can be 
reused over and over. Moreover, the biosensors are designed to give quick readouts of the sample. 
Therefore, once the antibodies are immobilized on the surfaces, the stability is not of concern, as the 
antibodies do not degrade within a few hours. However, if the sensors have to be used for onsite 
Figure 3. Procedure of antibodies immobilization: (a) Coated with 10 µL glutaraldehyde and incubated
with Argon Gas for 2 h; (b) Coated with 2 µL antibody for 1 h; (c) Immobilized antibodies; (d) 2 µL of
2% BSA was added and incubated for 30 min; (e) Added antigen (10, 5, 2.5, 1.25 mg/L); (f) Antibody
and antigen interaction.
After 2 h of incubation, the surfaces were thoroughly washed with PBS Tween-20/deionized
(DI) water. A drop-cast method was used to apply antibody (2 µL) on the surfaces with a fine
micropipette followed by incubation for 1 h at room temperature. The surfaces of the sensors were
washed again in a similar manner and immersed in a 2% BSA solution as a blocking reaction for
30 min at room temperature to avoid any non-specific binding. After blocking, surfaces were again
washed with the PBS Tween-20 buffer, which removes most of the unbound antibodies from the
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surfaces. Subsequently, the samples were incubated in the dark with a 2 µL solution of the SSAT
enzyme. Both antibody and antigen conjugation were detected by the change in capacitance. The
difference in capacitance corresponds to the concentration of the SSAT added after immobilization of
the antibody. The capacitive biosensor can be reused with extensive cleaning and recalibration of the
sensors. However, they get attached to the readout circuit via a simple connector and can be made
disposable due to the reduced cost of manufacturing them [22–34], while the electronic readout system
can be reused over and over. Moreover, the biosensors are designed to give quick readouts of the
sample. Therefore, once the antibodies are immobilized on the surfaces, the stability is not of concern,
as the antibodies do not degrade within a few hours. However, if the sensors have to be used for
onsite detection, then they have to be shipped using Peltier coolers. Another approach is to eliminate
certain factors that decrease the stability of biosensors [35]. Factors that affect the long-term stability of
biosensors include (1) fouling and contamination of the samples; (2) the lifetime of the immobilized
enzymes; and (3) strength of immobilization.
3. Successive Approximation Readout Circuit
There are several techniques for implementing the readout circuit for capacitive sensors such
as incremental sigma-delta, period modulation, successive approximation, and dual slope [25–29].
The successive approximation readout circuit is adopted to interface the fabricated biosensor, as it
achieves better energy efficiency.
The schematic of the readout circuit is shown in Figure 4. It is based on a successive-approximation
data converter that uses charge redistribution to produce a digital word. It consists of the unknown
capacitive sensor (CSENS), a binary-weighted DAC (CREF), an amplifier with feedback loop, a
single-ended comparator, and control SAR logic. The single-ended comparator consists of two cascaded
inverters with clocked latch based on NAND gates. The amplifier and comparator (cascaded inverters)
are implemented by using a clocked inverter. The circuit operation is divided into two phases: sampling
phase and conversion phase. Two standard non-overlapping clock phases, P1 and P2, are required
along with a SAR clock.
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To illustrate the readout circuit operation, Figure 5a shows the sampling phase of the readout
circuit. When clock phase P1 is high, the amplifier is configured as a unity-gain amplifier by turning
on the feedback switch. Thus, it employs the switching threshold voltage (VM1) to charge the
binary-weighted DAC, parasitic capacitance (CP), and the capacitive sensor (CSENS). The switches of
the binary-weighted DAC are implemented by inverters. They are used to drive the bottom plates
of the binary-weighted DAC to ground (GND) while the bottom plate of the sensing capacitor is
connected to reference voltage (VREF). The single-ended comparator for cascaded amplification is
turned off during this phase to reduce the average power consumption.Sensors 2017, 17, 1942  6 of 12 
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Figure 5. (a) Schematic and operation of sampling phase; (b) Schematic and operation of
conversion phase.
The second step is the conversion phase of the readout circuit, as shown in Figure 5b. In this
phase, the clock P1 is low and the feedback switch is turned off. Thus, an open-loop amplifier is
formed. Moreover, the bottom plates of the binary-weighted DAC are either connected to VREF or GND,
depending on the N-bit SAR logic output. The equivalent capacitance of the elements connected to
VREF and GND are CREF,ON and CREF,OFF, respectively, while the bottom plate of the sensing capacitor
is connected to GND. The single-ended comparator for cascaded amplification is turned on during
this phase. When the law of charge conservation is applied, the output voltage of the amplifier can be
expressed as
VOUT = VM1 + ∆Vo = VM1 +
(CSENS − CREF,ON) VREF
CT
A (1)
here A is the finite gain of the inverter, ∆VO is the change in the output voltage, and CT is (CSENS +
CREF + CP). Thus, the output voltage from the comparator is given by
VCMP =
{
0 ∆Vo < 0
1, ∆Vo > 0
(2)
The successive-approximation algorithm keeps changing CREF,ON until it matches CSENS with
an error less than 1 least-significant bit (LSB). The output voltage of the comparator is determined by
the sign of (CSENS − CREF,ON), regardless of its absolute value (∆VO). Thus, the circuit is insensitive to
VREF and CP variation. When the mismatch between the amplifier and the comparator is considered in
the analysis, the input voltage to the comparator is given by
VIN = VOUT − VM2 = (CSENS − CREF,ON) VREFCT A + VOS (3)
where VM2 is the switching threshold voltage of the comparator, and VOS is the offset voltage
(VM1 − VM2). Thus, the minimum achievable resolution is given by
LSB =
VOS
A VREF
CT (4)
Sensors 2017, 17, 1942 7 of 12
The LSB, gain, and full-scale range are therefore selected to limit the conversion error. For the
implemented readout circuit, the gain is 98, and the offset voltage is 3.3 mV.
The binary-weighted capacitive DAC is used to compare the digital output with the capacitive
input. The least-significant bit (LSB) capacitor is selected based on matching properties of the
capacitors. Fringing capacitance between metal wires on the same layer is used to implement the fine
binary-weighted DAC. Therefore, an 8-bit fine DAC with absolute resolution 4.5 fF is implemented.
The total fine DAC capacitance (composed of 255 units) is 1.147 pF. The metal-insulator-metal (MIM)
capacitor is used to implement the unit capacitor of the coarse binary-weighted DAC. It is chosen such
that the DNL of the coarse DAC is less than 1/2 LSB of the fine DAC and the full scale of the fine
DAC covers the unit capacitor of the coarse DAC. Therefore, a 4-bit coarse DAC with unit capacitor 1
pF is implemented and combined with fine DAC, which results in a 16.137 pF capacitance range in a
compact area.
4. Measurement Results
The prototype readout circuit was implemented in a standard 0.18 µm CMOS process. Figure 6
shows the chip photograph of the fabricated prototype. The active area is 0.06 mm2 including the
binary-weighted DAC, analog circuitry, and SAR control logic blocks. A register file is used to read
and write all digital signals through a 4-wire serial peripheral-interface (SPI) bus. The interface bus
minimizes the bond pads and package pins. A printed circuit board was designed and fabricated to
test the chip and the sensor. The chip was mounted on the circuit board and connected to the capacitive
biosensor, as shown in Figure 7.
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An on-chip dummy capacitive sensor is used to test the performance and the dynamic range of the
readout circuit. The measured transfer function of the readout circuit is shown in Figure 8. The curve
shows a linear relation between the output codes and input capacitances when the dummy capacitive
sensor varies between 0 and 16.137 pF in 4.5 fF steps. The circuit is quantization-noise limited, and the
noise is less than 1 LSB: i.e., it is limited by the smallest unit capacitor, as shown in Figure 9. It shows
the standard deviation of the measured readout-circuit output as a function of sensor capacitance.Sensors 2017, 17, 1942  8 of 12 
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the sensor is shown in Figure 10. The baseline capacitance of the sensors was about 26 fF while, the 
capacitance change was substantial (about 300 fF) upon adding antibodies and after immobilization. 
Further, upon adding BSA, the capacitance was unchanged or the change was negligible, showing 
the specificity of the immobilized antibodies. Figure 11 reports the sensor response to the different 
concentrations of the SSAT enzyme with respect to the baseline capacitance after antibody 
immobilization. The measurements show that the capacitance of the sensor increases with the 
decrease in concentration of the enzyme. The error bars show the variation in the change of 
capacitance for different samples. The mean and the standard deviation are shown for every 
concentration. The platform wakes up intermittently every 20 s to perform and digitize the 
measurement of the biosensor and then returns to sleep mode during the testing of the sample. The 
sensor shows the response and stabilization within 1 minute, which indicates a high sensitivity to 
SSAT enzyme concentrations. The average change in capacitance for the highest and the lowest 
concentration is 5 folds. Figure 12 shows the ratio of increase in the capacitance (CAntigen − 
CAntibody/CAntibody) with concentration. The ratio of capacitance increase was around 35 times for the 
concentration 1.25 mg/L and decreased to 6 times for the concentration 10 mg/L. This clearly indicates 
that a wide range of enzyme concentrations could be quantified using the diagnostic platform. The 
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levels in ma y can ers i l ding lun ], breast [37], prostat , el oma, and ga trointes inal
tract ca [38]. Th enzyme is lways present in all mammalian cells; the differen e is that
cancer patients have a igher roportion of the enzyme than healthy subjects. Th refore, various
concentrations of the antigen fro 10 to 1.25 mg/L have been screened. The change in capacitance
of the sensor is shown in Figure 10. The baseline capacitance of the sensors was about 26 fF
while, the capacitance change was substantial (about 300 fF) upon adding antibodies and after
immobilization. Further, upon adding BSA, the capacitance was unchanged or the change was
negligible, showing the specificity of the immobilized antibodies. Figure 11 reports the sensor response
to the different concentrations of the SSAT enzyme with respect to the baseline capacitance after
antibo y immobilizatio . The measurements s ow that the capacitance of the se sor in reases with the
decrease n co ntration of the enzyme. Th error bars show the variation in the change capacitance
for different samples. The ean and the standard deviation are shown for every concentration.
The platform wakes up intermittently every 20 s to perform and digitize the measurement of the
biosensor and then returns to sleep mode during the testing of the sample. The sensor shows
the response and stabilization within 1 min, which indicates a high sensitivity to SSAT enzyme
concentrations. The average change in capacitance for the highest and the lowest concentration is
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5 folds. Figure 12 shows the ratio of increase in the capacitance (CAntigen − CAntibody/CAntibody) with
concentration. The ratio of capacitance increase was around 35 times for the concentration 1.25 mg/L
and decreased to 6 times for the concentration 10 mg/L. This clearly indicates that a wide range of
enzyme concentrations could be quantified using the diagnostic platform. The platform can quantify
and digitize the given sample as low as 1.25 mg/L to 10 mg/L in its dynamic range with sufficient
margin for any offset or sensor capacitance variation.
Table 1 lists the performance of the readout circuit. It shows the measurement time and the average
power for analog and digital circuits. At full-scale input capacitance, the total power consumption of
the readout circuit is 2.1 µW, of which the analog represents 85.7% and the digital represents 14.3%.
Table 2 summarizes performance comparison with previously published Biosensor-CMOS
platforms. The introduced Biosensor-CMOS platform shows the ability to screen and quantify the SSAT
enzyme on the surface of the capacitive sensor. It is based on capacitive sensing, which is low-cost and
label-free. Moreover, the platform achieves an ultra-low power consumption of 2.1 µW among the
published platforms, which is four orders of magnitude less power than the state-of-the-art.
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Table 1. Readout circuit performance summary.
Technology CMOS 180 nm
Power Supply (Analog/Digital) 0.9 V/1 V
Absolute Resolution 4.5 fF
Capacitance Range 16.137 pF
Noise (rms) <1.4 fF
Power (Analog) 1.8 µW
Power (Digital) 0.3 µW
Resolution 12 Bits
Measurement Time 42.5 µs
Table 2. Comparison to some of the pre-existing biosensor-CMOS platforms.
Reference BIOCAS 2010 [11] JSSC 2013 [12] VLSI 2015 [13] JSSC 2013 [21] This Work
Target Protein Protein Protein P otein Protein
Technology (nm) 350 180 65 180 180
Sensing Parameter Impedance Magnetism Flu rescence Magnetism Capacitive
Target Protein Protein G Human serum albumin Streptavidin SLPI cancer marker SSAT enzyme
Transducer Au electrodes Hall sensor Photodetector GMR sensor Au electrodes
Labeling Label-free Magnetic particl Qdot 800 fluorophore Magnetic particle Label-free
Immobilization Yes Yes Yes Yes Yes
Power 84.8 mW 300 mW 66 mW 50.4 mW 2.1 µW
5. Conclusions
An in vitro diagnostic, biosensor-CMOS platform was developed to screen and quantify SSAT
enzyme for rapid detection that is low power and inexpensive. It will benefit early detection of
cancer, which dramatically improves the survival rate of cancer patients. A large sensing area
with small baseline capacitanc was introduced to implement a capacitive bi sensor that shows
a high sensitivity to SSAT enzyme concentrations. A successive readout circuit incorporating a
clocked inverter-based SAR architecture was introduced to read and process the information from
the biosensor. By using a clocked digital inverter as a quantizer, the readout circuit is able to achieve
an ultra-low power consumption. The diagnostic platform can be miniaturized into a complete
microsystem in a compact size by integrating the sensing electrode and the associated readout circuit
in a single tiny package. Therefore, the miniaturized device can be produced in low-cost, small size,
and mass-production technology.
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